atomoxetine hydrochloride has been researched along with Apnea, Obstructive Sleep in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 11 (64.71) | 2.80 |
| Authors | Studies |
|---|---|
| Azarbarzin, A; Braem, M; Calianese, N; Edwards, BA; Gell, L; Hamilton, GS; Hess, LB; Joosten, SA; Marques, M; Op de Beeck, S; Radmand, R; Redline, S; Sands, SA; Taranto-Montemurro, L; Vanderveken, OM; Vena, D; Verbraecken, J; Wellman, A; White, DP | 1 |
| Emsellem, HA; Maynard, JP; Sands, SA; Schweitzer, PK; Wylie, PE | 1 |
| Abe, M; Hayama, N; Ikeda, S; Kinouchi, T; Koshikawa, K; Ozawa, Y; Sakao, S; Sakuma, N; Sasaki, T; Sato, S; Shikano, K; Shiko, Y; Sugiyama, A; Suzuki, T; Tatsumi, K; Terada, J | 1 |
| Edwards, BA; Joosten, SA | 1 |
| Corser, B; Eves, E; Rucosky, G; Warren-McCormick, J | 1 |
| Messineo, L; Norman, D; Ojile, J | 1 |
| Bottrill, K; Combs, D; Edgin, J; Gerken, B; Hsu, CH; La Rue, S; Matloff, D; Parthasarathy, S; Van Vorce, H | 1 |
| Azarbarzin, A; Calianese, NA; Hess, LB; Messineo, L; Sands, SA; Taranto-Montemurro, L; Vena, D; Wellman, A; White, DP | 1 |
| Fabbro, CD; Herrero Babiloni, A; Lavigne, G; Mayer, P | 1 |
| Chang, HA; Chang, SY; Chen, TY; Chien, WC; Chung, CH; Kao, YC; Kuo, TBJ; Tzeng, NS; Yang, CCH | 1 |
| Adams, RJ; Carberry, JC; Carter, SG; Chiang, A; Eckert, DJ; Messineo, L; Taranto-Montemurro, L; Vakulin, A | 1 |
| Wadman, M | 1 |
| Berger, S; Fleury Curado, T; Polotsky, VY | 1 |
| Azarbarzin, A; Sands, SA; Taranto-Montemurro, L; Wellman, A | 1 |
| Althouse, AD; Patel, SR | 1 |
| Owens, JA; Sangal, J; Sangal, RB | 1 |
| Bart Sangal, R; Sangal, JM; Thorp, K | 1 |
6 trial(s) available for atomoxetine hydrochloride and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Topics: Atomoxetine Hydrochloride; Cross-Over Studies; Humans; Sleep; Sleep Apnea, Obstructive | 2023 |
Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
Topics: Atomoxetine Hydrochloride; Cross-Over Studies; East Asian People; Humans; Oxygen; Prospective Studies; Sleep Apnea, Obstructive | 2023 |
Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Topics: Atomoxetine Hydrochloride; Humans; Hypnotics and Sedatives; Pharynx; Sleep Apnea, Obstructive | 2023 |
The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.
Topics: Atomoxetine Hydrochloride; Child; Down Syndrome; Humans; Quality of Life; Sleep Apnea, Obstructive; Treatment Outcome | 2023 |
Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Continuous Positive Airway Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Middle Aged; Parasympatholytics; Polysomnography; Sleep; Sleep Apnea, Obstructive; Treatment Outcome | 2020 |
Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial.
Topics: Arousal; Atomoxetine Hydrochloride; Humans; Mandelic Acids; Sleep; Sleep Apnea, Obstructive; Zolpidem | 2021 |
11 other study(ies) available for atomoxetine hydrochloride and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Clinical polysomnographic methods for estimating pharyngeal collapsibility in obstructive sleep apnea.
Topics: Atomoxetine Hydrochloride; Humans; Male; Obesity; Oxygen; Pharynx; Sleep Apnea, Obstructive | 2022 |
Variability in the response to atomoxetine and oxybutynin for OSA: Highlighting the need for personalized medicine.
Topics: Atomoxetine Hydrochloride; Humans; Precision Medicine; Sleep; Sleep Apnea, Obstructive | 2023 |
The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial.
Topics: Atomoxetine Hydrochloride; Dronabinol; Humans; Oxygen; Polysomnography; Sleep Apnea, Obstructive | 2023 |
Could Atomoxetine-Oxybutynin, a Combination of Medications Being Explored for OSA Management, Have Any Effect on Sleep Bruxism or Jaw Muscle Tone?
Topics: Atomoxetine Hydrochloride; Humans; Mandelic Acids; Muscle Tonus; Sleep Apnea, Obstructive; Sleep Bruxism | 2021 |
Long-term atomoxetine-oxybutynin combination use may be beneficial for the prevention of obstructive sleep apnea.
Topics: Adolescent; Adult; Aged; Atomoxetine Hydrochloride; Child; Child, Preschool; Databases, Factual; Drug Discovery; Humans; Male; Mandelic Acids; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sleep Apnea, Obstructive; Taiwan; Young Adult | 2021 |
Drug pair shows promise for treating sleep apnea.
Topics: Airway Obstruction; Atomoxetine Hydrochloride; Humans; Mandelic Acids; Sleep Apnea, Obstructive | 2018 |
Pharmacotherapy of Obstructive Sleep Apnea: Is Salvation Just Around a Corner?
Topics: Atomoxetine Hydrochloride; Cross-Over Studies; Double-Blind Method; Humans; Mandelic Acids; Sleep Apnea, Obstructive | 2019 |
Reply to Patel and Althouse: Robust Methods Are Needed to Evaluate the Pharmacologic Treatment of Obstructive Sleep Apnea.
Topics: Atomoxetine Hydrochloride; Cross-Over Studies; Double-Blind Method; Humans; Mandelic Acids; Sleep Apnea, Obstructive | 2019 |
Robust Methods Are Needed to Evaluate the Pharmacologic Treatment of Obstructive Sleep Apnea.
Topics: Atomoxetine Hydrochloride; Cross-Over Studies; Double-Blind Method; Humans; Mandelic Acids; Sleep Apnea, Obstructive | 2019 |
Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Male; Methylphenidate; Nocturnal Myoclonus Syndrome; Polysomnography; Propylamines; Sleep; Sleep Apnea, Obstructive; Sleep Stages | 2005 |
Atomoxetine improves sleepiness and global severity of illness but not the respiratory disturbance index in mild to moderate obstructive sleep apnea with sleepiness.
Topics: Adrenergic Uptake Inhibitors; Adult; Arousal; Atomoxetine Hydrochloride; Attention; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Polysomnography; Propylamines; Sleep Apnea, Obstructive; Sleep Stages; Wakefulness; Young Adult | 2008 |